W. Kuhn

Interleukin-1β and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients

Doris Blum-Degena, Thomas Müller, W. Kuhn et al. · Neuroscience Letters · 1995 · 792 citations

Immunology, Neurochemical Biomarkers, Neuroinflammation +16

Facial expression recognition in people with medicated and unmedicated Parkinson’s disease

Reiner Sprengelmeyer, Andrew W. Young, K. Mahn et al. · Neuropsychologia · 2003 · 289 citations

Face Detection, Facial Recognition System, Facial Expression Recognition +9

Increased susceptibility to sporadic Parkinson's disease by a certain combined ?-synuclein/apolipoprotein E genotype

Rejko Kr�ger, Ana Vieira‐Saecker, W. Kuhn et al. · Annals of Neurology · 1999 · 279 citations

Genetics, German Pd Patients, Neurochemical Biomarkers +16

S-100 Protein: Serum Marker of Focal Brain Damage After Ischemic Territorial MCA Infarction

Thomas Büttner, Stephan Weyers, Thomas Postert et al. · Stroke · 1997 · 260 citations

Coenzyme Q10 supplementation provides mild symptomatic benefit in patients with Parkinson's disease

Thomas Müller, Thomas Büttner, Ali-Farshad Gholipour et al. · Neuroscience Letters · 2003 · 201 citations

Medicine, Parkinson Disease, Mild Symptomatic Benefit +4